Attachment I - Responses to Questions .pdf

Solicitation instructions

Statement of Work Attachment A - Relevant Experience Form Attachment B - Past Performance Questionnaire Attachment C - Pricing Worksheet Attachment E - Labor Category Descriptions Other

# RFP Reference Section & Page #s Question Agency Response

10. Instructions to Offerors and Evaluation/Award Criteria

1.0 Introduction; Page 94

The introductory paragraph states that the evaluation process will be conducted under the auspices of the Department of Homeland Security (DHS) Procurement Innovation Lab (PIL).

Will DHS participate in evaluating proposals or just the oversight of how the procurement is evaluated?

Proposals will be evaluated solely by the FDA. DHS is evaluating, reviewing, or providing oversight on this procurement. The PIL is serving as a consultant to the FDA as we implement innovative procurement techniques to streamline FDA procurement processes.

68 3.0 Schedule 3.0, p. 95 Would the Government provide an opportunity for Offerors to ask questions during Phase 2?

Per Section 9.0 ORAL PRESENTATION, Rules of Engagement item no.

4. The Offeror may not generally ask questions during the oral presentation. Any questions asked must be directed to the Contracting Officer/Contract Specialist and should only deal with logistics and conduct of the oral presentation. The FDA is only allowing for questions by the date provided in the solicitation and does not envision another round of questions and answers for Phase II vendors, but retains the right to do so if it is in the Government's best interest.

Attachment I - RFP Question Submittal Form; Solicitation No. 75F40123R00015

Prospective Offerors must use this form to submit all questions in relation to Solicitation No. 75F40123R00015.

The RFP Reference column should identify the RFP Section Title/Attachment associated with the question being asked.

Sheet1